Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

CKI requests to rejoin Thames Water auction - report

(Sharecast News) - Hong Kong infrastructure investor CK Infrastructure (CKI) has reportedly written to Thames Water to be let back into the bidding process for the struggling water company. According to Sky News, CKI has contacted Thames Water chair Adrian Montague to request access to due diligence information, just days after takeover talks with preferred bidder KKR collapsed.

CKI, which already owns Northumbrian Water and Northern Gas Networks, was in the running for the debt-laden utility group earlier in the year but faced fierce political opposition for its alleged links to the Chinese Community Party.

The letter, from CKI's deputy managing director Andy Hunter, indicated CKI's interest to be readmitted to the auction, with the investment firm able to make a formal bid within just six weeks, Sky News reported.

The developments came on the same day a group of Thames Water creditors proposed injecting billions into the stricken utility in exchange for regulatory leniency.

The creditors, which include Aberdeen, Elliott Management, Silver Point Capital and BlackRock, have submitted their plans to Ofwat. They have pledged to invest £3bn in new equity, raise a further £2bn and overhaul £17bn of Thames Water's debts.

The rescue package would lead to the "largest financial loss suffered by investors on an infrastructure asset in British history", the creditors claimed. However, in return they want the regulator to weaken both performance targets and compliance.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.